Ultralife (NASDAQ:ULBI) Upgraded at StockNews.com

Ultralife (NASDAQ:ULBI) was upgraded by investment analysts at StockNews.com from a “buy” rating to a “strong-buy” rating in a report issued on Wednesday.

Separately, Benchmark lifted their target price on shares of Ultralife from $12.00 to $13.00 and gave the stock a “buy” rating in a report on Tuesday, March 5th.

Ultralife Stock Performance

Shares of ULBI opened at $10.71 on Wednesday. The company has a market capitalization of $176.18 million, a PE ratio of 23.86 and a beta of 1.26. Ultralife has a one year low of $3.92 and a one year high of $11.85. The company has a debt-to-equity ratio of 0.19, a current ratio of 3.80 and a quick ratio of 2.02. The company’s fifty day moving average price is $9.13 and its 200 day moving average price is $8.19.

Ultralife (NASDAQ:ULBI) last announced its earnings results on Thursday, February 15th. The technology company reported $0.18 EPS for the quarter. The firm had revenue of $44.55 million for the quarter. Ultralife had a net margin of 4.54% and a return on equity of 7.36%.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in the stock. Healthcare of Ontario Pension Plan Trust Fund bought a new position in shares of Ultralife during the 3rd quarter worth about $36,000. LSV Asset Management increased its holdings in shares of Ultralife by 32.0% during the 3rd quarter. LSV Asset Management now owns 16,900 shares of the technology company’s stock worth $165,000 after purchasing an additional 4,100 shares during the period. Pitti Group Wealth Management LLC boosted its position in shares of Ultralife by 41.3% during the 4th quarter. Pitti Group Wealth Management LLC now owns 18,120 shares of the technology company’s stock valued at $124,000 after acquiring an additional 5,300 shares in the last quarter. Visionary Wealth Advisors boosted its position in shares of Ultralife by 0.7% during the 3rd quarter. Visionary Wealth Advisors now owns 1,072,249 shares of the technology company’s stock valued at $10,465,000 after acquiring an additional 7,070 shares in the last quarter. Finally, Citigroup Inc. acquired a new stake in shares of Ultralife during the 3rd quarter valued at about $74,000. Institutional investors own 30.68% of the company’s stock.

About Ultralife

Ultralife Corporation, together with its subsidiaries, designs, manufactures, installs, and maintains power, and communication and electronics systems worldwide. The company operates in two segments, Battery & Energy Products and Communications Systems. The Battery & Energy Products segment offers lithium 9-volt, cylindrical, thin lithium manganese dioxide, rechargeable, and other non-rechargeable batteries; lithium-ion cells, multi-kilowatt module lithium-ion battery systems, and uninterruptable power supplies; and rugged military and commercial battery charging systems and accessories, including smart chargers, multi-bay charging systems, and various cables.